Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy
Clinical trial NCT01843387 · COMPLETED
Trial details
- NCT number
- NCT01843387
- Sponsor
- Mesoblast, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2014-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.